New Approach for Ovarian PRP Injection for Poor Responders
NCT06663930 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 21
Last updated 2024-10-29
Summary
New Approach For Ovarian PRP Injection for poor responders
Conditions
- Poor Responders
Sponsors & Collaborators
-
Bassem Ayman Mahmoud Assaf
lead OTHER
Eligibility
- Min Age
- 30 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-01
- Primary Completion
- 2025-06-01
- Completion
- 2025-06-30
Countries
- Egypt
Study Locations
More Related Trials
-
Ovarian PRP Injection in Women With POR
NCT05601193 ·Status: RECRUITING ·Phase: NA
-
The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders
NCT05900661 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders
NCT05181748 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Efficacy of Platelets Rich Plasma for Ovarian Rejuvenation
NCT03946813 ·Status: COMPLETED ·Phase: NA
-
Magnetic Nanoparticle Sperm Separation for Teratozoospermia Male and Women Older Than 35 Years
NCT03666364 ·Status: COMPLETED ·Phase: NA
-
Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation
NCT05279560 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Intraovarian Platelet Rich Plasma in Women With Poor Ovarian Response and Premature Ovarian Insufficiency
NCT04237909 ·Status: COMPLETED ·Phase: NA
-
Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients
NCT04031456 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response
NCT04163640 ·Status: COMPLETED ·Phase: NA
-
Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium
NCT03166345 ·Status: COMPLETED ·Phase: NA
-
The Role of Ovarian PRP Therapy in Poseidon Poor Responders Women Undergoing ICSI Cycle
NCT07199868 ·Status: COMPLETED ·Phase: NA
-
Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
NCT07020546 ·Status: RECRUITING ·Phase: NA
-
Ovarian PRP for Diminished Ovarian Reserve
NCT05790655 ·Status: RECRUITING ·Phase: NA
-
Autologous Platelet-rich Plasma to Improve Responsiveness and Embryo Quality in Patients With Poor Ovarian Response
NCT05105724 ·Status: UNKNOWN ·Phase: PHASE2
-
Autologous Intraovarian Platelet Rich Plasma Treatment in Women With Poor Ovarian Response
NCT04797377 ·Status: COMPLETED ·Phase: NA
-
Primary Ovarian Insufficient Patients
NCT03989154 ·Status: RECRUITING
-
Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure
NCT02062931 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Fertility in Healthy Premenopausal Women
NCT02772848 ·Status: COMPLETED
-
Menstrual Blood Stem Cells in Poor Ovarian Responders
NCT05703308 ·Status: COMPLETED ·Phase: PHASE3
-
Intravascular Laser Irradiation of Blood Use in Poor Ovarian Responders
NCT05873075 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF)
NCT03069209 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Transplantation of Ovarian Cortex to Restore Fertility
NCT01442584 ·Status: UNKNOWN ·Phase: NA
-
Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure Women
NCT03365466 ·Status: UNKNOWN
-
Observational Study to Evaluate Fertility in Women Between 32 and 38 Years Old Treated With the Ovosicare® Fertility
NCT07083999 ·Status: RECRUITING
-
A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027)
NCT06930664 ·Status: COMPLETED ·Phase: PHASE1